Andrikopoulou, A.; Bletsa, G.; Rouvalis, A.; Tsakogiannis, D.; Kaparelou, M.; Papatheodoridi, A.; Haidopoulos, D.; Liontos, M.; Dimopoulos, M.-A.; Zagouri, F.
The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer. Cancers 2024, 16, 1962.
https://doi.org/10.3390/cancers16111962
AMA Style
Andrikopoulou A, Bletsa G, Rouvalis A, Tsakogiannis D, Kaparelou M, Papatheodoridi A, Haidopoulos D, Liontos M, Dimopoulos M-A, Zagouri F.
The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer. Cancers. 2024; 16(11):1962.
https://doi.org/10.3390/cancers16111962
Chicago/Turabian Style
Andrikopoulou, Angeliki, Garyfalia Bletsa, Angeliki Rouvalis, Dimitris Tsakogiannis, Maria Kaparelou, Alkistis Papatheodoridi, Dimitrios Haidopoulos, Michalis Liontos, Meletios-Athanasios Dimopoulos, and Flora Zagouri.
2024. "The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer" Cancers 16, no. 11: 1962.
https://doi.org/10.3390/cancers16111962
APA Style
Andrikopoulou, A., Bletsa, G., Rouvalis, A., Tsakogiannis, D., Kaparelou, M., Papatheodoridi, A., Haidopoulos, D., Liontos, M., Dimopoulos, M.-A., & Zagouri, F.
(2024). The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer. Cancers, 16(11), 1962.
https://doi.org/10.3390/cancers16111962
